Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tarnow

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 1996
Genetic pattern in diabetic nephropathyL Tarnow
Journal of the American Society of Nephrology : JASN|December 1, 1996
Genetics of diabetic nephropathyH H Parving, L Tarnow, P Rossing
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme geneL Tarnow, C Gluud, H H Parving
Diabetologia|February 23, 1999
Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathyA Sato, L Tarnow, H H Parving
Cardiology|January 1, 1997
Renal protection in diabetes--an emerging role for calcium antagonistsH H Parving, L Tarnow, P Rossing
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1996
Renal protection in diabetes: an emerging role for calcium antagonistsH H Parving, L Tarnow, P Rossing
Diabetes Care|September 4, 1998
Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathyA Sato, L Tarnow, H H Parving
Kidney International|April 14, 2006
Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?P K Jacobsen, L Tarnow, H-H Parving
Diabetic Medicine : a Journal of the British Diabetic Association|October 14, 2014
Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trialC Joergensen, L Tarnow, J P Goetze, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 20, 2007
CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathyM Lajer, L Tarnow, S Andersen, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 1996
Genetic pattern in diabetic nephropathyL Tarnow
Journal of the American Society of Nephrology : JASN|December 1, 1996
Genetics of diabetic nephropathyH H Parving, L Tarnow, P Rossing
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme geneL Tarnow, C Gluud, H H Parving
Diabetologia|February 23, 1999
Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathyA Sato, L Tarnow, H H Parving
Cardiology|January 1, 1997
Renal protection in diabetes--an emerging role for calcium antagonistsH H Parving, L Tarnow, P Rossing
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1996
Renal protection in diabetes: an emerging role for calcium antagonistsH H Parving, L Tarnow, P Rossing
Diabetes Care|September 4, 1998
Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathyA Sato, L Tarnow, H H Parving
Kidney International|April 14, 2006
Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?P K Jacobsen, L Tarnow, H-H Parving
Diabetic Medicine : a Journal of the British Diabetic Association|October 14, 2014
Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trialC Joergensen, L Tarnow, J P Goetze, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 20, 2007
CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathyM Lajer, L Tarnow, S Andersen, et al.
Pageof 11